Beta Bionics (BBNX) Non-Current Deffered Revenue (2023 - 2026)

Beta Bionics' Non-Current Deffered Revenue history runs 4 years deep, the most recent figure standing at $3.4 million for Q1 2026.

• In Q1 2026, Non-Current Deffered Revenue rose 43.78% year-over-year to $3.4 million; the TTM figure through Mar 2026 stood at $3.4 million (up 43.78% YoY), while the FY2025 annual figure was $3.3 million, up 77.26% from the prior year.
• Non-Current Deffered Revenue came in at $3.4 million for Q1 2026 at Beta Bionics, up from $3.3 million in the prior quarter.
• In the past five years, Non-Current Deffered Revenue ranged from a high of $3.4 million in Q1 2026 to a low of $255000.0 in Q4 2023.
• A 4-year average of $2.4 million and a median of $2.7 million in 2025 frame the typical range for Non-Current Deffered Revenue.
• Across the five-year window, Non-Current Deffered Revenue surged 629.41% in 2024 and surged 43.78% in 2026, its largest moves.
• Beta Bionics' Non-Current Deffered Revenue stood at $255000.0 in 2023, then soared by 629.41% to $1.9 million in 2024, then soared by 77.26% to $3.3 million in 2025, then gained by 1.61% to $3.4 million in 2026.
• According to Business Quant data, Non-Current Deffered Revenue over the past three periods registered $3.4 million, $3.3 million, and $3.0 million for Q1 2026, Q4 2025, and Q3 2025 respectively.

Peer Comparison